Chu de Bordeaux
Pessac, 33600, France
Location status: Recruiting
Location contact
BUSTIN Aurelien, PHD
CONTACT
Hubert COCHET
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05877755
Cardiovascular disease (CVD) causes at least 1.8 million European deaths annually, exceeding fatalities from cancer, chronic respiratory disease, and diabetes. Consequently, the fight against CVD has become the main priority of the World Health Organization. In the pursuit of understanding and treating CVD, cardiac magnetic resonance imaging (CMR) has remained the only modality capable of providing a comprehensive assessment of the heart's function and structure without harmful radiation. Unfortunately, current CMR systems remain too slow, too complex, require highly trained specialists and, as such, have presented a barrier to a wider adoption of CMR. The aim of CARDIO-IRM is to unleash the full potential of CMR to transform patient trajectories by introducing a fast, one-click, fully automated, and comprehensive imaging pipeline applicable to diagnosis, prognosis, and therapy selection in cardiology.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Pessac, 33600, France
Location status: Recruiting
BUSTIN Aurelien, PHD
CONTACT
Hubert COCHET
PRINCIPAL_INVESTIGATOR
Cardiovascular disease (CVD) causes at least 1.8 million European deaths annually, exceeding fatalities from cancer, chronic respiratory disease, and diabetes. Consequently, the fight against CVD has become the main priority of the World Health Organization. In the pursuit of understanding and treating CVD, cardiac magnetic resonance imaging (CMR) has remained the only modality capable of providing a comprehensive assessment of the heart's function and structure without harmful radiation. Unfortunately, current CMR systems remain too slow, too complex, require highly trained specialists and, as such, have presented a barrier to a wider adoption of CMR. The aim of this project is to unleash the full potential of CMR to transform patient trajectories by introducing a fast, one-click, fully automated, and comprehensive imaging pipeline applicable to diagnosis, prognosis, and therapy selection in cardiology.
This aim will be achieved by (i) creating a novel imaging technology that collects CMR data in a single continuous free-breathing scan, taking into account post-processing requirements at the very origin of CMR sequence design; (ii) exploiting the unique contrasts generated by this technology to automatically extract quantitative markers on cardiac anatomy, function, and tissue characteristics; and (iii) translating this transformative technology to a clinical setting.
This will be the first-ever integrated cardiac imaging pipeline in which CMR images are acquired in a single click, jointly represented in a single volume, and automatically analysed. This will unlock obstacles for broader acceptance of CMR and unleash the full potential of CMR to maximize its impact on patient trajectories. The results of this project will pave the way towards robust image-based strategies for personalized patient care (diagnosis, risk stratification, therapy selection, monitoring, and image-guided interventions).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients will have additional images collected during the magnetic resonance imaging (MRI) examination. These are high-resolution multi-contrast cardiac MRI sequences in gradient echo or in balanced steady state free precession with synchronization on the electrocardiogram. The acquisitions last between 1 minute and 10 minutes. This duration depends on the patient's heart rate and breathing rate. The imaging protocol will last approximately 50 minutes. MRI examinations will be performed on a 1.5 Tesla clinical system with specific cardiac imaging coils.
Time frame: 60 months
Measure of image quality according to signal-to-noise ratio
Time frame: 60 months
Measure of training time and training loss function
Time frame: 60 months
Measured in mL on late gadolinium enhancement images
Time frame: 60 months
Measured in milliseconds
Time frame: 60 months
Measured in mL/m2
Time frame: 60 months
Measured in percentage
Contact information is provided by the study sponsor or research team.
BUSTIN Aurelien, PHD
CONTACT
COCHET Hubert, MD, PHD
CONTACT
University Hospital, Bordeaux
Other
Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging (CARDIO IRM)
Acronym: CARDIO-IRM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04823663
Cardiac Disease, Cardiovascular Diseases
Jette, Belgium
View Trial DetailsNCT05786274
Brain Diseases, Cardiac Disease
San Donato Milanese, Milan, Italy
View Trial DetailsNCT06785181
Cardiac Disease, Cardiovascular Diseases
San Donato Milanese, Milano, Italy
View Trial DetailsNCT07217392
Arrhythmias, Cardiac, Atrial Fibrillation
Rio de Janeiro, Brazil
View Trial Details